Clinical Trial: Artificial Intelligence Enhanced Remote Monitoring in Interstitial Lung Disease

U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07844915) titled 'Artificial Intelligence Enhanced Remote Monitoring in Interstitial Lung Disease' on Sept. 16.

Brief Summary: The goal of this clinical trial is to learn whether artificial intelligence AI-enhanced remote monitoring (AIRM) is feasible, safe and acceptable for adults with fibrotic interstitial lung disease (fILD). The artificial intelligence (AI) system uses information collected through home monitoring to identify patterns that may suggest a person's lung condition is getting worse. The AI does not make treatment decisions. Its outputs are reviewed by healthcare professionals.

The main questions this study aims to answer are:

Is A...